Increased Anticoagulation During Cardiopulmonary Bypass by Prostaglandin E (1)
- 1 November 1998
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 87 (5) , 985-988
- https://doi.org/10.1213/00000539-199811000-00001
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effects of minimal-dose aprotinin on coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Prostaglandin E sub 1 Inhibits Platelet Decrease after Massive Blood Transfusions during Major SurgeryThe Journal of Trauma: Injury, Infection, and Critical Care, 1997
- Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: A clinical studyThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Low-dose and high-dose aprotinin improve hemostasis in coronary operationsThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Characterization of Prothrombin Activation during Cardiac Surgery by Hemostatic Molecular MarkersAnesthesiology, 1994
- Aprotinin in perspectiveThe Annals of Thoracic Surgery, 1993
- Effects of Alprostadil Infusion During Extracorporeal Circulation on Blood Rheology and Postoperative Blood LossVascular Surgery, 1992
- Prostaglandin E1: The endogenous physiological regulator of platelet mediated blood coagulationProstaglandins, Leukotrienes & Essential Fatty Acids, 1989
- The Effect of Prostaglandin E1 in Patients Undergoing Clinical Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1983
- Different Requirements for Intrinsic Factor‐Xa Forming Activity and Platelet Factor 3 Activity and their Relationship to Platelet Aggregation and SecretionBritish Journal of Haematology, 1978